MONTE ROSA
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90510273
- Registration number
- 7715410
- Mark type
- Stylized text
- Filed
- 04 Feb 2021
- Published for opposition
- 19 Oct 2021
- Registered
- 04 Mar 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic preparations for the treatment of cancer, immunological diseases, inflammatory diseases, neurological diseases, and genetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways
Owner
- Monte Rosa Therapeutics, Inc., Boston, MA, US
- Monte Rosa Therapeutics, Inc., Boston, MA, US
- Monte Rosa Therapeutics, Inc., Boston, MA, US
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Nov 2024 — USE AMENDMENT FILED
- 12 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 23 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2024 — SOU EXTENSION 5 GRANTED
- 22 Apr 2024 — SOU EXTENSION 5 FILED
- 22 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 4 GRANTED
- 28 Nov 2023 — SOU EXTENSION 4 FILED
- 28 Nov 2023 — SOU TEAS EXTENSION RECEIVED